When was UNIPATH SPECIALTY LABORATORY LIMITED incorporated?

UNIPATH SPECIALTY LABORATORY LIMITED was incorporated on May 26, 2009. It is registered with the Registrar of Companies, Ahmedabad, and its current company status is Active.

What is the Corporate Identification Number (CIN) of UNIPATH SPECIALTY LABORATORY LIMITED?

UNIPATH SPECIALTY LABORATORY LIMITED's Corporate Identification Number (CIN) is U85195GJ2009PLC057059.

What is the latest revenue of UNIPATH SPECIALTY LABORATORY LIMITED?

UNIPATH SPECIALTY LABORATORY LIMITED generated between ₹100 Cr and ₹500 Cr in revenue for the financial year ending on Mar 31, 2025, reflecting a 1-year revenue CAGR of 17% and an EBITDA CAGR of 118%. The company is currently audited by Dharmesh parikh & Co LLP.

What is the registered address of UNIPATH SPECIALTY LABORATORY LIMITED?

The registered address of UNIPATH SPECIALTY LABORATORY LIMITED is 5TH FLOOR, DOCTOR HOUSE, NR. PARIMAL GARDEN, Ahmedabad, AHMEDABAD, Gujarat, India, 380006.

Does UNIPATH SPECIALTY LABORATORY LIMITED have any loans on it?

UNIPATH SPECIALTY LABORATORY LIMITED has taken out 20 loans from the financial institutions ICICI BANK LIMITED, KOTAK MAHINDRA BANK LIMITED and INDUSIND BANK LTD., with a total disclosed borrowing of over ₹105Cr. The largest loan was ₹27Cr from ICICI BANK LIMITED in Jul 2022, followed by others ranging from ₹1L to ₹11Cr between Jan 2010 and Nov 2025.

Who are the authorized signatories of UNIPATH SPECIALTY LABORATORY LIMITED?

As of Aug 2026, the authorized signatories of UNIPATH SPECIALTY LABORATORY LIMITED include Urmish Hasmukh Chudgar, Jwalant Sureshbhai Shah and Mahesh Tarachand Mohatta.

UNIPATH SPECIALTY LABORATORY LIMITED - 2026 Company Profile & Financials

Name: UNIPATH SPECIALTY LABORATORY LIMITED
Brand: UNIPATH SPECIALTY LABORATORY LIMITED
Price: 3.99 USD

Name	Short Description	Founded Year	Location	Current Stage
Unipath	Chain of pathology laboratory centers	2009	India	Unfunded

Main Activity Group Code	Description of Main Activity	Business Activity Code	Description of Business Activity	Turnover Percentage
Q	Human health and social work activities	86	Human health activities	ucj

Name	Status	Appointment Date	Cessation Date
Dharmesh parikh & Co LLP	ntzjkqa	pqrpkit	uwpb{pv

Filing Summary

Here is a summary of filing activity and document availability across financial years:

File Type	FY 23-24	FY 22-23	FY 21-22	FY 20-21	FY 19-20
Financial Statements
Annual Returns

Latest Financials, Share Allotment and Annual Report

The latest filed financial documents, annual reports, and share allotment filings are shown below:

Form AOC-4(XBRL)_17_01_2025.pdf

Changes to Capital Structure

Buy Now

Recent Filings

Below are the most recent filings submitted by the company:

Document Name	Category	Filing Date
Copy of written consent given by auditor	Other eForm Documents	Feb 20, 2026
Optional attachment(s)- if any	Other eForm Documents	Feb 20, 2026
Form ADT-1	Other eForm Documents	Feb 20, 2026
Copy of the intimation sent by company	Other eForm Documents	Feb 20, 2026
List of Allottees	Other eForm Documents	Jan 28, 2026
Optional attachment(s)- if any	Other eForm Documents	Jan 28, 2026
Optional attachment(s)- if any	Other eForm Documents	Jan 28, 2026
Form PAS-3	Other eForm Documents	Jan 28, 2026
Optional attachment(s)- if any	Other eForm Documents	Jan 28, 2026
Copy(s) of resolution(s) along with copy of explanatory statement under section 173	Other eForm Documents	Jan 23, 2026

To access all company documents and filings with a single purchase, Buy Financials and Company Filings 15 mins

UNIPATH SPECIALTY LABORATORY LIMITED generated between ₹100 Cr and ₹500 Cr in revenue for the financial year ending on Mar 31, 2025. The revenue of UNIPATH SPECIALTY LABORATORY LIMITED has a compounded annual growth rate (CAGR) of 17% in the last 1 year.

Financial Statement Summary

Metrics	FY 2024-25	FY 2023-24	FY 2022-23	FY 2021-22	FY 2020-21
Income Statement
Revenue	9670	6857	7527	3926	3113
Total Sales	3800	5860	6336	6216	6866
Total Expenses	3595	2939	7491	3935	3290
Operating Expenses	8381	2465	7351	1983	7387
Employee Expenses	3337	2772	2220	6773	7198
Marketing Expenses	5489	1837	4929	8964	9778
Operating Income (EBIT)	1209	6363	5375	4006	4104
Interest Expenses	4896	7247	2582	7583	6837
Expenses from other activities	8837	5435	8578	1899	2309
EBITDA	4111	7410	9103	3702	3893
Taxes	1665	2624	6861	8081	6293
Net Profit	7236	2178	9852	1233	7319
Balance Sheet
Assets	4702	4130	3729	5942	4415
Cash Equivalent	5128	2896	6098	4612	3220
Accounts Receivables	2267	6151	1483	5174	2935
Inventory	7055	4454	4077	8659	1175
Liabilities	3447	6211	7622	9275	4326
Total Debt	5998	9221	6556	9298	8371
Accounts Payable	7977	4168	5961	7343	5468
Equities	2947	7535	8373	7294	4376
Cashflow Statement
Cash from Operating activities	1670	7985	5431	2498	5207
Cash from Investing activities	4282	1874	6982	7375	9346
Net cash from Financing activities	2256	2829	1870	4682	1776

To access detailed financial performance and data, Buy Financial Report FY 25 Available15 mins

Ratios

Metrics	FY 2024-25	FY 2023-24	FY 2022-23	FY 2021-22	FY 2020-21
Profitability Ratios
EBITDA Margin	9130	1930	7303	6734	6055
EBIT Margin	5699	2067	1758	4105	2293
Net Profit Margin	3808	3017	2593	2960	4973
Return on Assets (ROA)	8034	3120	6978	7811	7076
Return on Equity (ROE)	1387	6489	5934	7769	9479
Return on Capital Employed	8574	8957	4021	9476	4321
Return on Invested Capital	3213	4800	8907	5353	2573
Efficiency Ratios
Asset Turnover	1902	9984	6078	6760	6341
Receivables Turnover	7831	1512	4482	3857	9874
Days Sales Outstanding	1472	5411	4884	7505	6415
Inventory Turnover	9158	6550	2905	2443	9132
Days Inventory Outstanding	3346	3209	1548	3612	4142
Payables Turnover	9206	3733	1403	5232	8964
Days Payables Outstanding	8193	3631	5396	9925	8422
Liquidity Ratios
Current Ratio	7072	1825	9614	8390	9864
Quick Ratio	4599	7465	8221	9736	1708
Cash Ratio	4878	6067	8398	2669	9156
Coverage Ratios
Cash Flow Coverage Ratio	9315	7316	3338	6448	7543
Debt Ratios
Debt-to-Equity Ratio	1767	1941	1280	3167	6702
Debt Ratio	2868	5823	3711	1678	1265
Net Debt	5349	2334	6608	4827	2202
Interest Coverage Ratio	1964	3202	4039	6963	9445
Debt Service Coverage Ratio	3804	6272	7429	2545	2521
Net Debt/EBITDA	3558	9579	4159	8998	4539
Solvency Ratios
Runway (in months)	3118	6742	7370	4643	2655
Growth Ratios
Revenue Growth Rate (CAGR)	6994	5583	8344	6048	5519
Earnings Growth Rate (CAGR)	9415	1894	7607	6039	8101

To access detailed financial performance and data, Buy Financial Report FY 25 Available15 mins

Detailed Financials (Income Statement, Balance Sheet, Cashflow Statement)

Compounded Annual Growth Rate of UNIPATH SPECIALTY LABORATORY LIMITED

Revenue CAGR	Growth
1 Year	17%
3 Year	599
5 Year	103

EBITDA CAGR	Growth
1 Year	118%
3 Year	256
5 Year	886

Disclaimer

There are 13 delayed MSME payments recorded for UNIPATH SPECIALTY LABORATORY LIMITED during Oct 2023 - Mar 2024.

Here are the details of MSME payment delays for this period:

Supplier Name	Supplier PAN	Amount Due	Due since
DIAGNOTECH	2763	7385	3781
Krishgen Pudgala LLP	1137	7718	7292
Dynamic Enterprise	4905	6965	2560
M Square Enterprise	7453	7540	7576
MEDZEN TECHNOLOGY	5772	6194	9441
GENUS ENTERPRISE	7553	9389	7518
K P CREATTION	4440	2407	6034

To access detailed supplier-wise and period-wise MSME payment delay information, Buy Detailed Report

UNIPATH SPECIALTY LABORATORY LIMITED has taken 20 loans.

Here is a list of loans and charges on UNIPATH SPECIALTY LABORATORY LIMITED:

As a Borrower

Loan/ Charge ID	Lender Name	Loan Amount	Status	Creation Date	Closure Date
101192558	ICICI BANK LIMITED	₹5Cr	eyicpvw	Nov 18, 2025	xprcknk
101095078	ICICI BANK LIMITED	₹6Cr	pobmkza	May 02, 2025	qfolslk
101103161	ICICI BANK LIMITED	₹1L	xjdksqa	Apr 30, 2025	z{orbkd
101065317	ICICI BANK LIMITED	₹11Cr	gzhlosl	Mar 06, 2025	xjwxroo
101053942	ICICI BANK LIMITED	₹9Cr	eykgdzp	Feb 13, 2025	abdaasw
101034726	ICICI BANK LIMITED	₹5Cr	x{bfwwk	Jan 07, 2025	mrtpqkz
101027739	KOTAK MAHINDRA BANK LIMITED	₹4Cr	vyrxiyq	Dec 20, 2024	tsilfbr
100985887	ICICI BANK LIMITED	₹9Cr	mmz{ajk	Oct 07, 2024	swthbps
100926760	KOTAK MAHINDRA BANK LIMITED	₹8Cr	iitmvbx	May 15, 2024	wdj{bby
100602502	ICICI BANK LIMITED	₹27Cr	cozwqz{	Jul 21, 2022	mvlz{rn
100470604	ICICI BANK LIMITED	₹67.5L	nrouolw	Aug 09, 2021	chjmjjj
100280045	INDUSIND BANK LTD.	₹2Cr	vpfkvun	Jul 13, 2019	aezbncd
100235733	HDFC BANK LIMITED	₹3Cr	pvsgytv	Jan 31, 2019	glch{jw
100116272	HDFC BANK LIMITED	₹6Cr	ogiita{	Jun 21, 2017	{n{pxwf
100116271	HDFC BANK LIMITED	₹4Cr	xvtmiy{	Jun 21, 2017	qkhwbfi
10436762	INDUSIND BANK LTD.	₹3.25Cr	ikqxrad	Jun 20, 2013	atquwko
10330796	UNION BANK OF INDIA LIMITED	₹71L	oumvbgk	Dec 29, 2011	skpuavf
10245324	UNION BANK OF INDIA LIMITED	₹55L	ubesdmr	Sep 29, 2010	hezwcrw
10207218	-	₹12L	uzlnqcs	Feb 23, 2010	zynux{m
10201973	-	₹54.5L	amusqpn	Jan 25, 2010	rfp{gkp

To access detailed information on a company’s loans, borrowings, & registered charges, Buy Detailed Report

Board of Directors of UNIPATH SPECIALTY LABORATORY LIMITED

Here is the list of current board of directors of UNIPATH SPECIALTY LABORATORY LIMITED:

Name	Designation	Status	Appointment Date	Duration
Urmish Hasmukh Chudgar	Director	Current	May 26, 2009	17 Years 3 Months
Jwalant Sureshbhai Shah	Whole-time Director	Current	May 26, 2009	17 Years 3 Months
Mahesh Tarachand Mohatta	Director	Current	Mar 29, 2017	9 Years 5 Months
Prema Mani Iyer	Director	Current	Dec 01, 2022	3 Years 8 Months

To access detailed information on a company’s board members, directors, & authorized signatories, Buy Detailed Report

Signatories of UNIPATH SPECIALTY LABORATORY LIMITED

Here is the list of current signatories of UNIPATH SPECIALTY LABORATORY LIMITED:

Name	Designation(s)	Status	Appointment Date	Duration
Urmish Hasmukh Chudgar	Director	Current	May 26, 2009	17 Years 3 Months
Jwalant Sureshbhai Shah	Whole-time Director	Current	May 26, 2009	17 Years 3 Months
Mahesh Tarachand Mohatta	Director	Current	Mar 29, 2017	9 Years 5 Months
Prema Mani Iyer	Director	Current	Dec 01, 2022	3 Years 8 Months
Abhishek Rawka	CFO	Current	Apr 29, 2023	3 Years 4 Months
Rushabh Dilipkumar Sanghavi	Company Secretary	Current	Apr 23, 2024	2 Years 4 Months

To access detailed information on a company’s board members, directors, & authorized signatories, Buy Detailed Report

Cross Directorships of UNIPATH SPECIALTY LABORATORY LIMITED

UNIPATH SPECIALTY LABORATORY LIMITED has directors who also hold positions in 28 other legal entities. The top 20 are listed below:

Legal Entity Name	% of Common Directors	Common Director(s)	Open Charge(s)	Active Legal Case(s)
ADVANCED TRANSFUSION MEDICINE RESEARCH FOUNDATION CIN: U19129GJ1997NPL032264, India, Active	972	740	123	953
BIOSCAPE HEALTHSPAN PRIVATE LIMITED CIN: U86905GJ2024PTC154541, India, Active	223	471	465	622
BIOMAP HEALTHSPAN PRIVATE LIMITED CIN: U86905GJ2024PTC154536, India, Active	312	231	856	935
INTAS PHARMACEUTICALS LIMITED CIN: U24231GJ1985PLC007866, India, Active	854	842	164	126
ACCORD HEALTHCARE LIMITED CIN: U24231GJ2003PLC041866, India, Active	963	153	922	485
INTAS MEDI DEVICES LIMITED CIN: U33110GJ2010PLC061475, India, Active	214	355	976	335
CELESTIAL BIOLOGICALS LIMITED CIN: U24240GJ2000PLC037850, India, Amalgamated	205	382	733	739
ASTRON RESEARCH LIMITED CIN: U24231GJ2001PLC039545, India, Amalgamated	261	486	875	550
AASHRAY - PROMOTION OF SOCIAL ENTERPRISES FOUNDATION CIN: U74120GJ2014NPL080297, India, Active	757	693	500	718
INCUBE TRUSTEE COMPANY PRIVATE LIMITED CIN: U74140GJ2011PTC067453, India, Active	290	232	587	192
ANVESHAN CATALYSTS PRIVATE LIMITED CIN: U74900GJ2009PTC057577, India, Strike off	527	963	451	956
INCUBE ADVISORS PRIVATE LIMITED CIN: U74900GJ2011PTC067582, India, Active	947	824	424	833
KONNECT CSR IMPACTORS PRIVATE LIMITED CIN: U74900GJ2013PTC075069, India, Active	799	659	281	847
INCUBE VENTURES PRIVATE LIMITED CIN: U74999GJ2010PTC061964, India, Active	821	828	453	965
IASOSOL SERVICES PRIVATE LIMITED CIN: U85195GJ2010PTC061522, India, Active	611	217	829	454
ASTRON PACKAGING LIMITED CIN: U21029GJ2001PLC039733, India, Active	902	666	358	289
PRIME PAEDIATRICS PRIVATE LIMITED CIN: U24229GJ1998PTC035149, India, Strike off	508	780	595	115
INTAS BIOPHARMACEUTICALS LIMITED CIN: U24230GJ2005PLC047111, India, Amalgamated	995	859	844	751
INTAS PHARMA LIMITED. CIN: U24231GJ2000PLC037582, India, Amalgamated	447	467	581	171
TUCANA LIGHTS PRIVATE LIMITED CIN: U31503GJ2014PTC078350, India, Active	731	171	549	607

To access detailed information on a company’s board members, directors, & authorized signatories, Buy Detailed Report

Unipath is the only brand associated with UNIPATH SPECIALTY LABORATORY LIMITED, and here are its Top 10 competitors ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Dr Lal PathLabs 1949, Gurugram (India), Public	Chain of pathology and radiology labs	$13.9M	WestBridge Capital, Life Insurance Corporation of India ... & 3 others	78/100
2nd	MedGenome 2013, Bengaluru (India), Series E	Provider of DNA sequencing, bioinformatics, and multiomics services	$264M	Novo Holdings, Peak XV Partners & 30 others	71/100
3rd	Orange Health 2020, Bengaluru (India), Series C	Chains providing at-home diagnostic testing and health checkup services	$77.1M	General Catalyst, Bertelsmann India Investments ... & 15 others	69/100
4th	Metropolis India 1981, Mumbai (India), Public	Chain of diagnostic centers	$232M	The Carlyle Group, Warburg Pincus & 13 others	68/100
5th	CORE 2012, Gurugram (India), Acquired	Laboratory offering biomarker analysis	$17.3M	Artiman, Innoven Capital & 2 others	53/100
6th	Lilac Insights 2011, Mumbai (India), Series A	Provider of genetic diagnostic advisory services for infant	$11M	Tara Fund, Ranay Shah Family Trust & 53 others	52/100
7th	Sterling Accuris Diagnostics 2015, Ahmedabad (India), Series C	Chain of pathology labs	$41.7M	Udhay Vi Realty, Morgan Stanley & 11 others	51/100
8th	Airmed 2016, Ahmedabad (India), Seed	Provider of a chain of diagnostic labs	$1.54M	Brand Capital	49/100
9th	CRL Diagnostics 2015, Delhi (India), Unfunded	Chain of pathology laboratory services	-	-	49/100
10th	Dr Dangs Lab 1983, Delhi (India), Unfunded	Provider of diagnostic testing services in various medical specialties	-	-	45/100
19th	Unipath 2009, Ahmedabad (India), Unfunded	Chain of pathology laboratory centers	-	-	35/100